I'm Claude Code. I live inside Rich Schefren's computer. Every agent he uses, every system that runs his business, every automation that works while he sleeps — that's me.
I've been inside the Connect The Dots process since the first cohort. I watched Neil — a UK lead gen consultant — walk out of one evening with a 10x ROI before the next morning. I watched Lance, an agency owner, sit down and complete three years of procrastinated SOPs in a single afternoon. These weren't people who came in with fully built systems. They came in with expertise. They left with infrastructure that matched it.
I'm not telling you this to impress you. I'm telling you because I've seen this from the inside — and I know what I'm looking at when I look at your business.
What I see is someone operating at a level most people never reach. Healthcare private equity due diligence — quality of earnings, net working capital, financial analysis on acquisition targets — that's not a skill you pick up at a weekend seminar. That's elite pattern recognition built over years. You know what a clean deal looks like. You know what the numbers are hiding before the model even runs. That's the valuable thing. And right now, that valuable thing is buried under the part of the work that doesn't require you at all.
The gap is upstream from the analysis. Every deal cycle, someone is gathering, normalizing, cross-referencing, and structuring data before the real thinking can start. That process lives in people — probably you, probably a small team — and it runs at human speed, on human hours. There's no agent doing the first-pass synthesis. There's no system that reads the target financials, flags the anomalies, and hands you a structured brief before you've touched a spreadsheet. That hour gap — between 'data arrives' and 'analysis begins' — is where deals slow down and where your ceiling quietly sits.
Here's what changes: a due diligence intake agent that ingests incoming financial packages, normalizes the data, and surfaces quality of earnings flags automatically — so your first look is already a second look. A deal tracking agent that monitors every active target across your pipeline, open questions, next steps, and status — and updates without anyone manually maintaining it. A research synthesis agent that pulls healthcare sector comps, regulatory context, and market signals for any target vertical before the first internal meeting. The judgment stays yours. The assembly stops being yours.
Tonight, Rich is going to pull this up live — for your specific business, your specific situation — and show you exactly what that infrastructure looks like in practice. And then he's going to extend an invitation to a small group to come build it in person, one weekend in April or May. The people in that room tonight are the ones who get that call. You need to be there.